Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use
Author:
Affiliation:
1. Epidemiology; Optum; Ann Arbor MI USA
2. Center for Observational Research; Amgen Inc.; Thousand Oaks CA USA
3. Pharmacoepidemiology and Risk Management; RTI Health Solutions, Research Triangle Park; NC USA
4. Amgen Inc.; Thousand Oaks CA USA
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Reference28 articles.
1. Tumor-necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review;Marchioni;World J Gastroenterol,2013
2. Placental tumor necrosis factor-α protein expression during normal human gestation;Basu;J Matern Fetal Neonatal Med,2016
3. Biologic therapies and pregnancy: the story so far;Hyrich;Rheumatology,2014
4. Treatment with biologics of pregnant patients with rheumatic diseases;Østensen;Curr Opin Rheumatol,2011
5. State of the art: reproduction and pregnancy in rheumatic diseases;Østensen;Autoimmun Rev,2015
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pregnancy and neonatal outcomes in pregnant patients with inflammatory arthropathy treated by etanercept; Retrospective study ‎;Journal of Advanced Pharmacy Education and Research;2024
2. New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations;International Journal of Molecular Sciences;2023-07-28
3. Exposure to biologic therapy before and during pregnancy in patients with psoriasis: Systematic review and meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2023-06-13
4. Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes;Drug Safety;2023-01-19
5. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids;Rheumatology;2022-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3